These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39068670)

  • 1. Systematic characterization of the expression, prognosis and immune characteristics of PLOD family genes in breast cancer.
    Wang DD; Li L; Fu YQ; Yang SJ; Chen X; Hou JC; Zhang Q; Tian XX; Tang JH; Zhang J; Zhang HD
    Aging (Albany NY); 2024 Jul; 16(14):11434-11445. PubMed ID: 39068670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma.
    Yang B; Zhao Y; Wang L; Zhao Y; Wei L; Chen D; Chen Z
    Front Oncol; 2020; 10():1695. PubMed ID: 33014843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer.
    Zhang J; Tian Y; Mo S; Fu X
    Int J Gen Med; 2022; 15():3077-3096. PubMed ID: 35330878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
    Chen R; Jiang M; Hu B; Fu B; Sun T
    Int J Gen Med; 2023; 16():707-722. PubMed ID: 36872941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer.
    Qi Q; Huang W; Zhang H; Zhang B; Sun X; Ma J; Zhu C; Wang C
    Transl Cancer Res; 2021 Jun; 10(6):2707-2724. PubMed ID: 35116582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpressing PLOD family genes predict poor prognosis in gastric cancer.
    Li SS; Lian YF; Huang YL; Huang YH; Xiao J
    J Cancer; 2020; 11(1):121-131. PubMed ID: 31892979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Prognostic Value of the
    Meng Y; Sun J; Zhang G; Yu T; Piao H
    Front Mol Biosci; 2021; 8():770729. PubMed ID: 35265665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
    Jiang H; Guo W; Yuan S; Song L
    Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
    Li G; Wang X; Liu G
    Biomed Res Int; 2021; 2021():5512340. PubMed ID: 34258263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43.
    Guo T; Gu C; Li B; Xu C
    Lab Invest; 2021 May; 101(5):564-569. PubMed ID: 33483598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).
    Gong S; Duan Y; Wu C; Osterhoff G; Schopow N; Kallendrusch S
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of PLOD family members in low-grade gliomas using bioinformatics methods.
    Zhao Y; Zhang X; Yao J
    PLoS One; 2021; 16(1):e0246097. PubMed ID: 33503035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Profiling Identifies
    Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
    Front Immunol; 2021; 12():722807. PubMed ID: 34646265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
    Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of PLODs in Collagen Synthesis and Cancer Progression.
    Qi Y; Xu R
    Front Cell Dev Biol; 2018; 6():66. PubMed ID: 30003082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
    Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
    Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment.
    Huo X; Shen G; Li J; Wang M; Xie Q; Zhao F; Ren D; Dong Q; Zhao J
    Gene; 2022 Feb; 812():146094. PubMed ID: 34896519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer.
    Lin T; Qiu Y; Peng W; Peng L
    Biomed Res Int; 2020; 2020():2148253. PubMed ID: 33145341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
    Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
    Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.